160 likes | 411 Views
Medicines Optimisation. This meeting is organised and funded by Pfizer. UK/PHP/13/0087 May 2013. Agenda. Pfizer Healthy Partnerships and the Pharmacy Development Team Medicines Optimisation definition Patient outcomes 2012 campaign overview and results
E N D
Medicines Optimisation This meeting is organised and funded by Pfizer UK/PHP/13/0087 May 2013
Agenda • Pfizer Healthy Partnerships and the Pharmacy Development Team • Medicines Optimisation definition • Patient outcomes • 2012 campaign overview and results • Medicines Optimisation future developments
Pharmacy Development Team: Strategy • Stand out as the leadership company for pharmacy for support, knowledge and collaboration • Demonstrate the value of pharmacy within the local and national healthcare environment • Continue partnering to deliver positive outcomes for pharmacy and Pfizer in reputation
Improving quality, value and outcomes for patients from use of their medicines Higher level of engagement with patients and the public Breaking down barriers between the professions Incorporates concordance and adherence, more sophisticated than medicines management Medicines Optimisation - definition1 1. Keith Ridge; http://www.pjonline.com/news/straight_from_the_horse%E2%80%99s_mouth_%E2%80%94_medicines_optimisation_explained, March 2013 Dr Keith Ridge, Chief Pharmaceutical Officer England
A challenge to measure Patient outcomes
Medicines Optimisation Campaign (2012) 2 Launched to raise awareness: • Importance of taking medicines as prescribed • Benefits to patient health • Better value for NHS • Position community pharmacists as medicines experts • Encourage patient engagement with community pharmacy 2. Medicines Optimisation poster, Pfizer data on file Sept 2012
Medicines Optimisation Campaign (2012) 2 Launched in two phases: • Pharmacy media and Consumer media • Print, online media, Pharmacy Show • Radio campaign • Posters • Access Pfizer 2. Medicines Optimisation poster, Pfizer data on file Sept 2012
Regional versions (England) 3. Regional Medicines Optimisation posters, Pfizer, data on file Sept 2012
Results 2 national consumer pieces 24 medical online & print articles 12 regional online newspapers 3,275,481 total reach 10 regional radio bulletins 48 social media posts 4. Data on file, Nov 2012
Medicines Optimisation future developments: • Develop a better understanding of how Medicines Optimisation can be supported by the Professional Bodies and the ABPI • Develop a better understanding of how patient behaviour influences Medicines Optimisation • Develop a better understanding of how Medicines Optimisation can improve patient outcomes
References • Keith Ridge interview, PJ online March 2013 http://www.pjonline.com/news/straight_from_the_horse%E2%80%99s_mouth_%E2%80%94_medicines_optimisation_explained • Medicines Optimisation poster (national), Sept 2012 • Medicines Optimisation posters (regional), Sept 2012 • Data on file, results of media campaign, Nov 2012 • Ref quoted re £300M: Evaluation of the Scale,Causes and Costs of Waste Medicines, York Health Econimics Consortium and School of Pharmacy, University of London, Nov 2010